Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of Efficacy and Safety of Genolar® and Xolar® in Treating Patients With Moderate to Severe Persistent Atopic Bronchial Asthma Inadequately Controlled With Stage 4 GINA (2017) Treatment

NCT04607629 is registered in ClinicalTrials.gov with AO GENERIUM as lead sponsor.

NCT NCT04607629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of Efficacy and Safety of Genolar® and Xolar® in Treating Patients With Moderate to Severe Persistent Atopic Bronchial Asthma Inadequately Controlled With Stage 4 GINA (2017) Treatment
Lead sponsor
AO GENERIUM
Phase
Phase 3
Overall status
Completed
Start date
June 20, 2018
Completion date
December 13, 2019
Enrollment
192 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

bronchial asthma